Clinical Trial Update: Furosemide Versus Ethacrynic Acid in Children With Congenital Heart Disease [Phase 3]

View source ↗

Summary

A Phase 3 trial comparing furosemide to ethacrynic acid in children with congenital heart disease and fluid overload has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Congenital Heart Disease
• Fluid Overload

Drugs mentioned

• ETHACRYNIC ACID (Ethacrynic acid)
• FUROSEMIDE (Furosemide)

Snippet

Sponsor: Bambino Gesù Hospital and Research Institute | Conditions: Fluid Overload | Phase 3 | Status: COMPLETED